Literature DB >> 15339241

The psychological burden of short stature: evidence against.

Linda D Voss1, David E Sandberg.   

Abstract

Short stature, per se, is clearly not a disease, but is commonly perceived to be associated with social and psychological disadvantage. The assumption, widely held by pediatricians that short children are likely to be significantly affected by their stature, has been founded largely on older, poorly designed clinic-based studies and laboratory investigations of beliefs about the association between stature and individual characteristics. In contrast, data from more recent and better designed clinic- and community-based studies show that, in terms of psychosocial functioning, individuals with short stature are largely indistinguishable from their peers, whether in childhood, adolescence or adulthood. Parents and children alike should be reassured by these findings. In the absence of clear pathology, physical or psychological, GH therapy for the short but otherwise normal child raises ethical concerns about so-called 'cosmetic endocrinology'.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339241     DOI: 10.1530/eje.0.151s029

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

1.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Authors:  John D Mahan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

2.  Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naïve, growth-hormone-treated, and healthy samples.

Authors:  Matthew D Stephen; James W Varni; Christine A Limbers; Michael Yafi; Rubina A Heptulla; Venkat S Renukuntla; Cynthia S Bell; Patrick G Brosnan
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

3.  Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease.

Authors:  Joachim Rosenkranz; Evelyn Reichwald-Klugger; Jun Oh; Martin Turzer; Otto Mehls; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

4.  Idiopathic short stature: decision making in growth hormone use.

Authors:  Nidhi Maheshwari; Naveen K Uli; Sumana Narasimhan; Leona Cuttler
Journal:  Indian J Pediatr       Date:  2011-11-19       Impact factor: 1.967

Review 5.  "Anything you can do, I can do bigger?": the ethics and equity of growth hormone for small normal children.

Authors:  D G Gill
Journal:  Arch Dis Child       Date:  2006-03       Impact factor: 3.791

6.  A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs.

Authors:  Amir S Khan; Ruxandra Draghia-Akli; Roman J Shypailo; Kenneth I Ellis; Harry Mersmann; Marta L Fiorotto
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

7.  Medical, cognitive and academic outcomes of very low birth weight infants at age 10-14 years in Ireland.

Authors:  Fiona McNicholas; Elaine Healy; Martin White; Margaret Sherdian-Pereira; Niamh O'Connor; Susie Coakley; Barbara Dooley
Journal:  Ir J Med Sci       Date:  2013-12-04       Impact factor: 1.568

8.  Medicalising short children with growth hormone? Ethical considerations of the underlying sociocultural aspects.

Authors:  Maria Cristina Murano
Journal:  Med Health Care Philos       Date:  2018-06

9.  Effects of Phlomis umbrosa Root on Longitudinal Bone Growth Rate in Adolescent Female Rats.

Authors:  Donghun Lee; Young-Sik Kim; Jungbin Song; Hyun Soo Kim; Hyun Jung Lee; Hailing Guo; Hocheol Kim
Journal:  Molecules       Date:  2016-04-07       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.